Skip to main content
Top
Published in: BMC Physiology 1/2004

Open Access 01-12-2004 | Research article

Exercise increases endostatin in circulation of healthy volunteers

Authors: Jian-Wei Gu, Giovani Gadonski, Julie Wang, Ian Makey, Thomas H Adair

Published in: BMC Physiology | Issue 1/2004

Login to get access

Abstract

Background

Physical inactivity increases the risk of atherosclerosis. However, the molecular mechanisms of this relation are poorly understood. A recent report indicates that endostatin, an endogenous angiostatic factor, inhibits the progression of atherosclerosis, and suggests that reducing intimal and atherosclerotic plaque tissue neovascularization can inhibit the progression atherosclerosis in animal models. We hypothesize that exercise can elevate the circulatory endostatin level. Hence, exercise can protect against one of the mechanisms of atherosclerosis.

Results

We examined treadmill exercise tests in healthy volunteers to determine the effect of exercise on plasma levels of endostatin and other angiogenic regulators. Oxygen consumption (VO2) was calculated. Plasma levels of endostatin, vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) were determined using ELISA. The total peak VO2 (L) in 7 male subjects was 29.5 ± 17.8 over a 4–10 minute interval of exercise. Basal plasma levels of endostatin (immediately before exercise) were 20.3 ± 3.2 pg/ml, the plasma levels increased to 29.3 ± 4.2, 35.2 ± 1.8, and 27.1 ± 2.2 ng/ml, at 0.5, 2, and 6 h, respectively, after exercise. There was a strong linear correlation between increased plasma levels of endostatin (%) and the total peak VO2 (L) related to exercise (R2 = 0.9388; P < 0.01). Concurrently, VEGF levels decreased to 28.3 ± 6.4, 17.6 ± 2.4, and 26.5 ± 12.5 pg/ml, at 0.5, 2, and 6 h, respectively, after exercise. There were no significant changes in plasma bFGF levels in those subjects before and after exercise.

Conclusions

The results suggest that circulating endostatin can be significantly increased by exercise in proportion to the peak oxygen consumption under physiological conditions in healthy volunteers. These findings may provide new insights into the molecular links between physical inactivity and the risk of angiogenesis dependent diseases such as atherosclerosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Booth FW, Gordon SE, Carlson CJ, Hamilton MT: Waging war on modern chronic disease: primary prevention through exercise. J Appl Physiol. 2000, 88: 774-787.PubMed Booth FW, Gordon SE, Carlson CJ, Hamilton MT: Waging war on modern chronic disease: primary prevention through exercise. J Appl Physiol. 2000, 88: 774-787.PubMed
2.
go back to reference Francis K: The burden of physical inactivity and cardiovascular heart disease. Compr Ther. 1998, 24: 87-92.PubMed Francis K: The burden of physical inactivity and cardiovascular heart disease. Compr Ther. 1998, 24: 87-92.PubMed
3.
go back to reference Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampper MJ, Willett WC, Speizer FE, Hennekens CH: A prospective study of walking compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med. 1999, 341: 650-568. 10.1056/NEJM199908263410904.CrossRefPubMed Manson JE, Hu FB, Rich-Edwards JW, Colditz GA, Stampper MJ, Willett WC, Speizer FE, Hennekens CH: A prospective study of walking compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med. 1999, 341: 650-568. 10.1056/NEJM199908263410904.CrossRefPubMed
4.
go back to reference Berlin JA, Colditz GA: A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990, 132: 612-628.PubMed Berlin JA, Colditz GA: A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990, 132: 612-628.PubMed
5.
go back to reference Wannamethee SG, Shaper AG: Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med. 2001, 31: 101-114.CrossRefPubMed Wannamethee SG, Shaper AG: Physical activity in the prevention of cardiovascular disease: an epidemiological perspective. Sports Med. 2001, 31: 101-114.CrossRefPubMed
6.
go back to reference Tan KH, de Cossart L, Edwards PR: Exercise training and peripheral vascular disease. Br J Surgery. 2000, 87: 553-562. 10.1046/j.1365-2168.2000.01445.x.CrossRef Tan KH, de Cossart L, Edwards PR: Exercise training and peripheral vascular disease. Br J Surgery. 2000, 87: 553-562. 10.1046/j.1365-2168.2000.01445.x.CrossRef
7.
go back to reference Sacco RL, Benjamin EG, Broderick JP: Risk factors (AHA conference proceedings). Stroke. 1997, 28: 1507-1517.CrossRefPubMed Sacco RL, Benjamin EG, Broderick JP: Risk factors (AHA conference proceedings). Stroke. 1997, 28: 1507-1517.CrossRefPubMed
8.
go back to reference O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Folkman J: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994, 145: 883-94.PubMedCentralPubMed O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Folkman J: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994, 145: 883-94.PubMedCentralPubMed
9.
go back to reference Isner JM: Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation. 1999, 99: 1653-1655.CrossRefPubMed Isner JM: Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation. 1999, 99: 1653-1655.CrossRefPubMed
10.
go back to reference Kahlon R, Shapero J, Gotlieb AI: Angiogenesis in atherosclerosis. Can J Cardiol. 1992, 8: 60-64.PubMed Kahlon R, Shapero J, Gotlieb AI: Angiogenesis in atherosclerosis. Can J Cardiol. 1992, 8: 60-64.PubMed
11.
go back to reference Walsh K, Isner JM: Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall. Cardiovasc Res. 2000, 45: 756-765. 10.1016/S0008-6363(99)00270-9.CrossRefPubMed Walsh K, Isner JM: Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall. Cardiovasc Res. 2000, 45: 756-765. 10.1016/S0008-6363(99)00270-9.CrossRefPubMed
12.
go back to reference Boehm T, Folkman J, Browder T, O'Reilly MS: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997, 390: 404-7. 10.1038/37126.CrossRefPubMed Boehm T, Folkman J, Browder T, O'Reilly MS: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature. 1997, 390: 404-7. 10.1038/37126.CrossRefPubMed
13.
go back to reference O'Reilly MS, Boehm T, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997, 88: 277-285.CrossRefPubMed O'Reilly MS, Boehm T, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997, 88: 277-285.CrossRefPubMed
14.
go back to reference Obeso J, Weber J, Auerbach R: A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest. 1990, 63: 359-69. Obeso J, Weber J, Auerbach R: A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest. 1990, 63: 359-69.
15.
go back to reference Moulton KS, Heller E, Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999, 99: 1726-32.CrossRefPubMed Moulton KS, Heller E, Folkman J: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999, 99: 1726-32.CrossRefPubMed
16.
go back to reference Elastad MH: Stress testing protocol. In: Stress Testing: Principles and Practice. Edited by: Elastad MH. 1996, Philadelphia, PA: F. A Davis Company Elastad MH: Stress testing protocol. In: Stress Testing: Principles and Practice. Edited by: Elastad MH. 1996, Philadelphia, PA: F. A Davis Company
17.
go back to reference Feldman AL, Tamarkin L, Paciotti GF, et al: Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res. 2000, 6: 4628-4634.PubMed Feldman AL, Tamarkin L, Paciotti GF, et al: Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res. 2000, 6: 4628-4634.PubMed
18.
go back to reference Standker L, Schrader M, Kanse SM, Jurgens M, Forssmann WG, Preissner KT: Isolation and characterization of the circulating form of human endostatin. FEBS Lett. 1997, 420: 129-133. 10.1016/S0014-5793(97)01503-2.CrossRefPubMed Standker L, Schrader M, Kanse SM, Jurgens M, Forssmann WG, Preissner KT: Isolation and characterization of the circulating form of human endostatin. FEBS Lett. 1997, 420: 129-133. 10.1016/S0014-5793(97)01503-2.CrossRefPubMed
19.
go back to reference Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J-M: Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000, 486: 247-251. 10.1016/S0014-5793(00)02249-3.CrossRefPubMed Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J-M: Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 2000, 486: 247-251. 10.1016/S0014-5793(00)02249-3.CrossRefPubMed
20.
go back to reference Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T: The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in human. Am J Pathol. 1998, 153: 611-26.PubMedCentralCrossRefPubMed Saarela J, Rehn M, Oikarinen A, Autio-Harmainen H, Pihlajaniemi T: The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in human. Am J Pathol. 1998, 153: 611-26.PubMedCentralCrossRefPubMed
21.
go back to reference Kovanen V, Suominen H: Age- and training-related changes in the collagen metabolism of rat skeletal muscle. Eur J Appl Physiol. 1989, 58: 765-771.CrossRef Kovanen V, Suominen H: Age- and training-related changes in the collagen metabolism of rat skeletal muscle. Eur J Appl Physiol. 1989, 58: 765-771.CrossRef
22.
go back to reference Thomas DP, McCormick RJ, Zimmerman SD, Vadlamudi RK, Gosselin LE: Aging- and training-induced alterations in collagen characteristics of rat left ventricle and papillary muscle. Am J Physiol Heart Circ Physiol. 1992, 263: H778-H783. Thomas DP, McCormick RJ, Zimmerman SD, Vadlamudi RK, Gosselin LE: Aging- and training-induced alterations in collagen characteristics of rat left ventricle and papillary muscle. Am J Physiol Heart Circ Physiol. 1992, 263: H778-H783.
23.
go back to reference White FC, Bloor CM, McKirnan MD, Carroll SM: Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol. 1998, 85: 1160-1168.PubMed White FC, Bloor CM, McKirnan MD, Carroll SM: Exercise training in swine promotes growth of arteriolar bed and capillary angiogenesis in heart. J Appl Physiol. 1998, 85: 1160-1168.PubMed
24.
go back to reference Hang J, Kong L, Gu J-W, Adair TH: VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol Heart Circ Physiol. 1995, 269: H1827-31. Hang J, Kong L, Gu J-W, Adair TH: VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle. Am J Physiol Heart Circ Physiol. 1995, 269: H1827-31.
25.
go back to reference Adair TH, Gay WJ, Montani J-P: Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol Regul Integr Comp Physiol. 1990, 259: R393-R404. Adair TH, Gay WJ, Montani J-P: Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol Regul Integr Comp Physiol. 1990, 259: R393-R404.
26.
go back to reference Breen EC, Johnson EC, Wagner H, Tseng HM, Sung SA, Wagner PT: Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol. 1996, 81: 355-361.PubMed Breen EC, Johnson EC, Wagner H, Tseng HM, Sung SA, Wagner PT: Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol. 1996, 81: 355-361.PubMed
27.
go back to reference Asano M, Kaneoka K, Nomura T, Asano K, Sone H, Tsurumaru K, Yamashita K, Matsuo K, Suzuki H, Okuda Y: Increase in serum vascular endothelial growth factor levels during altitude training. Acta Physiol Scand. 1998, 162: 455-459. 10.1046/j.1365-201X.1998.0318e.x.CrossRefPubMed Asano M, Kaneoka K, Nomura T, Asano K, Sone H, Tsurumaru K, Yamashita K, Matsuo K, Suzuki H, Okuda Y: Increase in serum vascular endothelial growth factor levels during altitude training. Acta Physiol Scand. 1998, 162: 455-459. 10.1046/j.1365-201X.1998.0318e.x.CrossRefPubMed
28.
go back to reference Gu J-W, Santiago D, Olowe Y, Weinberger J: Basic fibroblast growth factor as a biochemical marker of exercise-induced ischemia. Circulation. 1997, 95: 1156-68.CrossRef Gu J-W, Santiago D, Olowe Y, Weinberger J: Basic fibroblast growth factor as a biochemical marker of exercise-induced ischemia. Circulation. 1997, 95: 1156-68.CrossRef
29.
go back to reference Gunga H-C, Kirsch K, Rocker L, Behn C, Koralewski E, Davila EH, Estrada MI, Johannes B, Wittels P, Jelkmann W: Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol. 1999, 79: 484-90. 10.1007/s004210050541.CrossRef Gunga H-C, Kirsch K, Rocker L, Behn C, Koralewski E, Davila EH, Estrada MI, Johannes B, Wittels P, Jelkmann W: Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol. 1999, 79: 484-90. 10.1007/s004210050541.CrossRef
30.
go back to reference Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ: Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol. 1999, 276: H679-H685. Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ: Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol. 1999, 276: H679-H685.
31.
go back to reference Richardson RS, Wagner H, Mudaliar RSD, Saucedo E, Henry R, Wagner PD: Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol. 2000, 279: H772-H778.PubMed Richardson RS, Wagner H, Mudaliar RSD, Saucedo E, Henry R, Wagner PD: Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol. 2000, 279: H772-H778.PubMed
32.
go back to reference Anthony FW, Evans PW, Wheeler T, Wood PJ: Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem. 1997, 34: 276-280.CrossRefPubMed Anthony FW, Evans PW, Wheeler T, Wood PJ: Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem. 1997, 34: 276-280.CrossRefPubMed
33.
go back to reference Celletti FL, Hilfiker PR, Ghafouri P, Dake MD: Effect of human recombinant vascular endothelial growth factor 165 on progression of atherosclerotic plaque. J Am Coll Cardiol. 2001, 37: 2126-2130. 10.1016/S0735-1097(01)01301-8.CrossRefPubMed Celletti FL, Hilfiker PR, Ghafouri P, Dake MD: Effect of human recombinant vascular endothelial growth factor 165 on progression of atherosclerotic plaque. J Am Coll Cardiol. 2001, 37: 2126-2130. 10.1016/S0735-1097(01)01301-8.CrossRefPubMed
34.
go back to reference Lemstrom KB, Krebs R, Nykanen AI, Tikkanen JM, Sihvola RK, Aaltola EM, Hayry PJ, Wood J, Alitalo K, Vla-Herttuata S, Koskinen PK: Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation. 2002, 105: 2524-2530. 10.1161/01.CIR.0000016821.76177.D2.CrossRefPubMed Lemstrom KB, Krebs R, Nykanen AI, Tikkanen JM, Sihvola RK, Aaltola EM, Hayry PJ, Wood J, Alitalo K, Vla-Herttuata S, Koskinen PK: Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation. 2002, 105: 2524-2530. 10.1161/01.CIR.0000016821.76177.D2.CrossRefPubMed
35.
go back to reference Isner JM, Losordo DW: Therapeutic angiogenesis for heart failure. Nat Med. 1999, 5: 491-492. 10.1038/8374.CrossRefPubMed Isner JM, Losordo DW: Therapeutic angiogenesis for heart failure. Nat Med. 1999, 5: 491-492. 10.1038/8374.CrossRefPubMed
Metadata
Title
Exercise increases endostatin in circulation of healthy volunteers
Authors
Jian-Wei Gu
Giovani Gadonski
Julie Wang
Ian Makey
Thomas H Adair
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Physiology / Issue 1/2004
Electronic ISSN: 1472-6793
DOI
https://doi.org/10.1186/1472-6793-4-2

Other articles of this Issue 1/2004

BMC Physiology 1/2004 Go to the issue